Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients
NCT ID: NCT06614699
Last Updated: 2024-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
8000 participants
OBSERVATIONAL
2012-01-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients
NCT06606912
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660
Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer
NCT02800005
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429
Frailty Trajectories and Their Association With Health Outcomes
NCT05793229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Case collection Patients diagnosed with colorectal cancer and undergoing radical colorectal cancer surgery were screened according to the inclusion criteria. All patients had signed informed consent. Inclusion criteria: (1) Diagnosed with colorectal cancer by pathology or cytology; (2) Age \>18 years; (3) Not having received chemotherapy, radiotherapy, targeted therapy or immunotherapy; (4) Patients with postoperative pathological stages other than stage IV, or without metastases in liver, lung or other distant organs confirmed by CT, MRI or B-ultrasound imaging and without surgical treatment; (5) Pre-operative CT examination data were kept in our hospital.
2. Data collection Collect patients' preoperative baseline information such as gender, age, body mass index (BMI), complications, tumor stage, etc. Collect patients' preoperative CT scans (make sure to include images from lumbar 1 to lumbar 5). Collect patients' surgical conditions such as operation time and intraoperative bleeding. Collect patients' postoperative complications during hospitalization;
3. Prognostic follow-up Closely follow up the death or cancer recurrence of patients after surgery.
4. Outcome indicators (1) Primary outcome indicators: overall survival (OS), disease-free survival (DFS), postoperative complications. (2) Secondary outcome indicators: postoperative recovery time, hospitalization time, postoperative weight change.
5. Image processing 3D Slicer was used to outline the range of subcutaneous fat, visceral fat, and muscle at the level of waist 1 to waist 5 on enhanced CT (5.0mm) images. Export the segmentation result as gpj.format, and select the Area Reading Calculator to calculate the area of fat and muscle at each level. Calculate fat area and muscle area at each level, calculate overall abdominal fat area and muscle area, and use the ratio of fat area to muscle area (e.g., visceral fat/skeletal muscle) as a predictor to generate the desired quantitative analyses.
6. Statistical Analysis (1) Basic characteristics and imaging indices were described as mean and standard deviation or median and standard deviation. (2) Univariate analysis including Kaplan-Meier survival analysis and Log-rank test were used to evaluate the effects of fat and muscle area on postoperative survival and complications. (3) Multivariate analysis including Cox regression models or Logistic regression models were used to evaluate the independent predictive role of abdominal fat and muscle area on surgical outcomes, controlling for potential confounders (e.g., age, gender, BMI, tumor stage, etc.).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the colorectal cancer group
Abdominal fat and muscle area were calculated based on abdominal CT of colorectal cancer patients.
abdominal fat and muscle area
Abdominal fat and muscle area were calculated based on abdominal CT.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
abdominal fat and muscle area
Abdominal fat and muscle area were calculated based on abdominal CT.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2, aged \>18 years;
* 3, not received chemotherapy, radiotherapy, targeted therapy or immunotherapy;
* 4, post-operative pathological stages other than stage IV, or no liver, lung or other organs as confirmed by CT, MRI, B-ultrasound imaging.
* 5, patients who have pre-operative CT examination data kept in our hospital.
Exclusion Criteria
* 2, refusal to participate in this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Affiliated Hospital of Chongqing Medical University
OTHER
Chongqing Medical University
OTHER
First Affiliated Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Peng
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dong Peng, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Yongchuan Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sahin MEH, Akbas F, Yardimci AH, Sahin E. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer. BMC Cancer. 2023 Sep 28;23(1):911. doi: 10.1186/s12885-023-11423-y.
Arulananda S, Segelov E. Sarcopenia and cancer-related inflammation measurements in advanced gastric and junctional cancers-ready for prime time? Ann Oncol. 2022 Jul;33(7):669-671. doi: 10.1016/j.annonc.2022.04.008. Epub 2022 Apr 14. No abstract available.
Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med. 2020 Nov;9(21):7964-7978. doi: 10.1002/cam4.3428. Epub 2020 Sep 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZZ2024-158-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.